We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Internal Medicine

Integrating Exercise and Medication Management in Geriatric Care: A Holistic Approach to Improve Health Outcomes and Reduce Polypharmacy

MedXY Editorial Team•Oct 20, 2025•Internal Medicine
exercise therapygeriatricspolypharmacy

Introduction

The growing global population of older adults, defined as those aged 60 years or more, presents complex challenges for healthcare systems worldwide. Older adults typically have multimorbidity and are frequently prescribed multiple medications, known as polypharmacy, elevating the risk of adverse drug reactions, drug interactions, and medication nonadherence. Recently published insights emphasize integrating exercise prescriptions into medication management as an innovative, holistic approach to optimize health outcomes in geriatric care. This article critically examines the rationale, evidence, and practical considerations underpinning this strategy to enhance therapeutic efficacy, minimize the harms of polypharmacy, and improve functional status among older adults.

Background: Burden of Multimorbidity and Polypharmacy in Older Adults

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Transforming Readmission Risk After Colorectal Surgery in Older Adults: From Nonmodifiable to Actionable Geriatric and Comorbidity FactorsThis study highlights that geriatric vulnerabilities and comorbidities, once considered nonmodifiable, play a dominant role in 30-day readmissions after colorectal surgery in older adults, emphasizing the need for integrated perioperative iAug 25, 2026Polypharmacy Challenges in Older Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease: Navigating Care in a High-Risk PopulationOlder adults with MASLD, especially those aged 75 and above, experience a high burden of polypharmacy linked to multimorbidity, necessitating careful medication management to balance disease control and geriatric vulnerabilities.Jul 17, 2026Combined Nicotinamide Riboside and Home-Based Exercise Improved Peak VO2 Safely in Friedreich’s AtaxiaIn a phase 2 factorial trial, 12 weeks of nicotinamide riboside plus individualized exercise improved cardiopulmonary fitness in Friedreich’s ataxia, with mild-to-moderate adverse events and no signal of major safety concerns.May 3, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Optimizing Influenza Protection in the Aging Diabetic Population: Evidence from the DANFLU-2 High-Dose Vaccine Trial
This secondary analysis of the DANFLU-2 trial demonstrates that high-dose influenza vaccines provide superior protection against cardiorespiratory and cardiovascular hospitalizations in older adults with diabetes, particularly those with a
Mar 28, 2026
Optimizing Influenza Protection in Older Adults with Diabetes: Insights from the DANFLU-2 TrialA secondary analysis of the DANFLU-2 trial confirms that high-dose influenza vaccine significantly reduces cardiorespiratory hospitalizations in older adults with diabetes, with potentially enhanced benefits for those with longer disease duMar 18, 2026
SGLT2 Inhibitors Reduce Gout-Related Medication Burden in Patients with Type 2 DiabetesA large-scale target trial emulation study demonstrates that SGLT2 inhibitors significantly reduce the initiation of allopurinol and the use of anti-inflammatory medications in patients with comorbid gout and type 2 diabetes, offering a potMar 6, 2026